Your browser doesn't support javascript.
loading
Phenoxyalkylimidazoles with an oxadiazole moiety are subject to efflux in Mycobacterium tuberculosis.
Thayer, Mai B; Parish, Tanya.
Afiliação
  • Thayer MB; TB Discovery Research, Infectious Disease Research Institute, Seattle, WA, United States of America.
  • Parish T; TB Discovery Research, Infectious Disease Research Institute, Seattle, WA, United States of America.
PLoS One ; 16(1): e0239353, 2021.
Article em En | MEDLINE | ID: mdl-33481781
ABSTRACT
The phenoxyalkylimidazoles (PAI) are an attractive chemical series with potent anti-tubercular activity targeting Mycobacterium tuberculosis respiration. Our aim was to determine if the PAI compounds are subject to efflux. Two analogs containing an oxadiazole had improved potency in the presence of the efflux inhibitors reserpine and carbonyl cyanide m-chlorophenylhydrazine, whereas the potency of analogs with a diazole was not affected.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oxidiazóis / Fenóis / Mycobacterium tuberculosis Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oxidiazóis / Fenóis / Mycobacterium tuberculosis Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos